Here are relevant reports on : ai-in-market-research
-
Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Asia Pacific biomarkers Market, valued at US$13.51 billion in 2024, stood at US$14.73 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$26.40 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Robotics AI Software Market Size, Share & Trends by Component (Software Platforms, Middleware, Analytics & Monitoring Tools, AI Development Frameworks), Cloud, On-Premises, Hybrid, Industrial Robots, Manufacturing, Logistics & Warehousing- Global Forecast to 2032
The global Robotics AI Software Market is estimated at USD 21.0 billion in 2025 and is projected to reach USD 70.8 billion by 2032, growing at a CAGR of 19.0% from 2026 to 2032. Growth is being driven by the convergence of artificial intelligence, industrial automation, simulation platforms, computer vision, robotics foundation models, and the emergence of physical AI systems capable of operating in increasingly complex real-world environments.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
North America Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)-Forecast to 2030
The North America biomarkers Market, valued at US$23.35 billion in 2024, stood at US$25.13 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$45.25 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Generative AI Market by Software (Foundation Models, Model Enablement & Orchestration Tools, Gen AI SaaS), Modality (Text, Code, Video, Image, Multimodal), Application (Content Management, BI & Visualization, Search & Discovery) - Forecast to 2032
The Europe generative AI market size is projected to grow from USD 16.56 billion in 2025 to USD 202.77 billion by 2032, at a CAGR of 43.0% during the forecast period. The Key Players include Accenture (Ireland), Mistral AI (France), Stability AI (UK), Capgemini (France), Synthesia (UK), DeepSearch Labs (UK), Colossyan (UK), InstaDeep (UK), LightOn (France), Mostly.ai (Austria), TextCortex (Germany), Zama AI (France), Synthflow (Germany), Otera (Austria), and Recraft (UK).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Europe biomarkers Market, valued at US$16.40 billion in 2024, stood at US$17.46 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$28.11 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021
The global cell sorting market is projected to grow at a CAGR of 7.0%. Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028
The global research antibodies & reagents market, valued at US$1.3 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 45.6% from 2023 to 2028, culminating in a forecasted valuation of US$12.1 billion by the end of the period. The growth of this market is largely driven by an increase in research activity—especially in the life sciences industry—along with growing industry-academia collaborations are a primary growth driver for this market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecast to 2020
The global qPCR reagents market size is projected to grow at a CAGR of 7.7%. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Retail Market by Solution (Personalized Product Recommendation, Visual Search, Virtual Stores, Virtual Customer Assistant, CRM), Type (Generative AI, Other AI), End-user (Online, Offline) - Global Forecast to 2030
The AI in retail market is projected to reach USD 164.74 billion by 2030, at a CAGR of 32.0% during the forecast period. Microsoft (US), IBM (US), Google (US), Amazon (US), Oracle (US), Salesforce (US), NVIDIA (US), SAP (Germany), ServiceNow (US), Accenture (Ireland), Infosys (India), Alibaba (China), Intel (US), AMD (US), Fujitsu (Japan), Capgemini (France), TCS (India), Talkdesk (US), Symphony AI (US), Bloomreach (US), C3.AI (US), Visenze (Singapore), Pathr.ai (US), Vue.AI (US), Nextail (Spain), Daisy Intelligence (Canada), Cresta (US), Mason (US), Syte (Israel), Trax (Singapore), Feedzai (US), and Shopic (Israel).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Europe Artificial Intelligence (AI) Market by Infrastructure (Compute, Memory, Networking, Storage), Software (Conversational Assistants, No Code/Low Code, BI & Analytics, Developer Platforms), Technology (ML, NLP, Generative AI) - Forecast to 2032
The Europe AI market size was estimated at USD 86.24 billion in 2025 and is projected to reach USD 548.03 billion by 2032, growing at a CAGR of 30.2% from 2025 to 2032. The major players in the Europe AI market include SAP (Germany), Microsoft (US), IBM (US), Oracle (US), AWS (US), Siemens (Germany), NVIDIA (US), OpenAI (US), Google (US), H2O.ai (US), and Salesforce (US), along with startups/SMEs such as Graphcore (UK), DeepL (Germany), Synthesia (UK), and Gamaya (Switzerland).
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
